Saxagliptin
Drug timelines are a Plus or Pro feature.
55 regulatory and trial events tracked for Saxagliptin, covering 2009-09-25 to 2026-03-13. Get the full timeline:
Most recent: EMA Authorised: Qtern (saxagliptin;dapagliflozin propanediol monohydrate) — Astra Zeneca AB